Clinical Trial Update: Effect of IDEA-070 on Pain and Inflammation Induced by PDT [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated IDEA-070 for reducing pain and inflammation induced by photodynamic therapy in actinic keratosis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• IDEA-070

Snippet

Sponsor: IDEA AG | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED